Owner LFB Biotechnologies

Inventors Beliard, Rolan; Bihoreau, Nicolas; Bourel, Dominique; Glacet, Arnaud; Nony, Emanuel; de Romeuf , Christophe

Agent Freehills

Pub. Number AU-A-2012203957

Parent 2010257417

Filing date 5 July 2012

Wipo publication date 26 July 2012

C12N 15/09 Mutation or genetic engineering - Recombinant DNA-technology

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61P 7/00 Drugs for disorders of the blood or the extracellular fluid

A61P 15/00 Drugs for genital or sexual disorders

A61P 31/00 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 Antineoplastic agents

A61P 37/02 Drugs for immunological or allergic disorders

A61P 37/06 Drugs for immunological or allergic disorders

C07K 16/34 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 5/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 5/20 Undifferentiated human, animal or plant cells, e.g. cell lines - one of the fusion partners being a B lymphocyte

C12N 15/02 Mutation or genetic engineering - Preparation of hybrid cells by fusion of two or more cells, e.g. protoplast fusion

C12N 15/13 Mutation or genetic engineering - Immunoglobulins

C12P 21/08 Preparation of peptides or proteins - Monoclonal antibodies